Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Cardiol Therapeutics Inc T.CRDL

Alternate Symbol(s):  CRDL

Cardiol Therapeutics Inc. is a clinical-stage life sciences company. The Company is focused on the research and clinical development of anti-inflammatory and anti-fibrotic therapies for the treatment of heart disease. Its lead drug candidate, CardiolRx (cannabidiol) oral solution, is pharmaceutically manufactured and in clinical development for use in the treatment of heart disease. It is recognized that cannabidiol inhibits activation of the inflammasome pathway, an intracellular process known to play an important role in the development and progression of inflammation and fibrosis associated with myocarditis, pericarditis, and heart failure. It is also developing CRD-38, a novel subcutaneously administered drug intended for use in heart failure. It has received Investigational New Drug Application authorization from the United States Food and Drug Administration to conduct clinical studies to evaluate the efficacy and safety of CardiolRx in two diseases affecting the heart.


TSX:CRDL - Post by User

Bullboard Posts
Comment by TechnicallyHighon Apr 08, 2019 10:47am
53 Views
Post# 29596450

RE:9$ based on nothing

RE:9$ based on nothing

LongandDong wrote:

nobody will distibute cbd synthetics at any level




Ill bet you $100K that major retailers, pharmacies, cannabis stores etc will be distributing CardiolRX by 2020. 
 

Tom Moffatt is very likely already talking to the pharmacies about getting this on shelves. 

Why you think anyone would trust the opinion of a moronic stockhouse shorter who has proven zero credibility, on how pharma grade CBD will be accepted is beyond me. There is a good chance that most consumers who buy CBD products wont even KNOW if they have real or sythetic materials. 

Also - if people start giving their pets CBD... Im sure pet food makers will have a real issue with dogs knowing the difference between CBD from plant or CBD from pharma. Pretty sure the beverages people dont get a F either. 

Here is an article talking about how CBD is heavily in demand but there isnt enough supply. 

https://www.cbc.ca/news/canada/newfoundland-labrador/cbd-shortage-1.5083180?__vfz=medium%3Dsharebar

WrongandDong strikes again. Keep on saying dumb s&it. its easy to knock each point down with common sense. 

Bullboard Posts